Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Iannacone

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Nature Cancer|March 4, 2022
The interaction of CD4<sup>+</sup> helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade responseMerav Cohen, Amir Giladi, Oren Barboy, et al.
Science Translational Medicine|January 10, 2024
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virusFrancesco Andreata, Kelly D Moynihan, Valeria Fumagalli, et al.
The Journal of Experimental Medicine|June 8, 2018
The Rho regulator Myosin IXb enables nonlymphoid tissue seeding of protective CD8<sup>+</sup> T cellsFederica Moalli, Xenia Ficht, Philipp Germann, et al.
The Journal of Experimental Medicine|September 13, 2023
The guanine nucleotide exchange factor Rin-like controls Tfh cell differentiation via CD28 signalingLisa Sandner, Marlis Alteneder, Ramona Rica, et al.
Science (New York, N.Y.)|April 30, 2026
Lymphoid tissue chemokines limit priming duration to preserve CD8<sup>+</sup> T cell functionalityLukas M Altenburger, Daniela Claudino Carvoeiro, Philippe Dehio, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2022
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulatorsLeda Ivanova Bencheva, Lorena Donnici, Luca Ferrante, et al.
EMBO Molecular Medicine|March 22, 2023
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responsesValeria Fumagalli, Pietro Di Lucia, Micol Ravà, et al.
Cell|April 21, 2015
Immunosurveillance of the liver by intravascular effector CD8(+) T cellsLuca G Guidotti, Donato Inverso, Laura Sironi, et al.
Science Immunology|November 22, 2016
Inflammatory monocytes hinder antiviral B cell responsesStefano Sammicheli, Mirela Kuka, Pietro Di Lucia, et al.
Nature Communications|August 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8<sup>+</sup> T cell responsivenessIsabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Nature Cancer|March 4, 2022
The interaction of CD4<sup>+</sup> helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade responseMerav Cohen, Amir Giladi, Oren Barboy, et al.
Science Translational Medicine|January 10, 2024
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virusFrancesco Andreata, Kelly D Moynihan, Valeria Fumagalli, et al.
The Journal of Experimental Medicine|June 8, 2018
The Rho regulator Myosin IXb enables nonlymphoid tissue seeding of protective CD8<sup>+</sup> T cellsFederica Moalli, Xenia Ficht, Philipp Germann, et al.
The Journal of Experimental Medicine|September 13, 2023
The guanine nucleotide exchange factor Rin-like controls Tfh cell differentiation via CD28 signalingLisa Sandner, Marlis Alteneder, Ramona Rica, et al.
Science (New York, N.Y.)|April 30, 2026
Lymphoid tissue chemokines limit priming duration to preserve CD8<sup>+</sup> T cell functionalityLukas M Altenburger, Daniela Claudino Carvoeiro, Philippe Dehio, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2022
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulatorsLeda Ivanova Bencheva, Lorena Donnici, Luca Ferrante, et al.
EMBO Molecular Medicine|March 22, 2023
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responsesValeria Fumagalli, Pietro Di Lucia, Micol Ravà, et al.
Cell|April 21, 2015
Immunosurveillance of the liver by intravascular effector CD8(+) T cellsLuca G Guidotti, Donato Inverso, Laura Sironi, et al.
Science Immunology|November 22, 2016
Inflammatory monocytes hinder antiviral B cell responsesStefano Sammicheli, Mirela Kuka, Pietro Di Lucia, et al.
Nature Communications|August 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8<sup>+</sup> T cell responsivenessIsabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi, et al.
Pageof 14